NVAX reports encouraging third-quarter results. However, the stock falls due to management lowering its sales guidance, ...

J.P. Morgan analyst Eric Joseph maintained a Sell rating on Novavax (NVAX – Research Report) yesterday and set a price target of $9.00. Eric Joseph has given his Sell rating due to a combination of ...

DENVER (KDVR) — Pilots at Frontier Airlines spent Tuesday afternoon picketing in front of the company’s Denver headquarters ...

The US Food and Drug Administration (FDA) has removed the clinical hold on the Investigational New Drug (IND) application for ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of ...

NovaVax Inc.’s stock NVAX tumbled 7% early Tuesday, after the company cut its full-year guidance, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue. The company ...

Vistara operated its last flight from Kolkata on Monday before seamlessly transitioning to Air India. The emotional farewell ...

Italy's largest bank Intesa Sanpaolo said it would partner with BlackRock , the world's biggest asset manager and a leading Intesa shareholder, to offer digital wealth management services to clients ...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Coherus is resuming the supply of its ...

If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. It takes the body about two weeks to build up immunity after either shot — meaning vaccination is needed before ...